1010 - Toll-like receptor 9 signalling is a potential tumour escape mechanism following B-cell receptor targeted treatments in subsets of patients with Chronic Lymphocytic Leukaemia.

Primary Author / Presenter(s)

LS

Lauren Stott, MSc

Brighton and Sussex Medical School
Brighton, England, United Kingdom
IA

Iona Ashworth, MD

Brighton & Sussex Medical School, England, United Kingdom
RJ

Rosalynd Johnston, MD

University Hospitals Sussex NHS Foundation Trust
Brighton, England, United Kingdom
JJ

John Jones, MD, PhD

East Sussex Healthcare NHS Trust
Eastbourne, England, United Kingdom
EL

Eleni Ladikou, MD, PhD

East Sussex Healthcare NHS Trust
Eastbourne, England, United Kingdom
VG

Valter Gattei

Centro di Riferimento Oncologico di Aviano
Aviano, Friuli-Venezia Giulia, Italy
AZ

Antonella Zucchetto

Centro di Riferimento Oncologico di Aviano
Aviano, Friuli-Venezia Giulia, Italy
FS

Fabio Simoes, PhD

Brighton and Sussex Medical School
Brighton, England, United Kingdom
SM

Simon Mitchell, PhD

Brighton and Sussex Medical School
Brighton, England, United Kingdom
CP

Chris Pepper, PhD

Brighton and Sussex Medical School
Brighton, England, United Kingdom
Andrea Pepper, PhD

Brighton and Sussex Medical School
University of Sussex
Brighton, England, United Kingdom